Novel theranostic approach for treating pancreatic cancer patients shows promise

0

(Society of Nuclear Medicine and Molecular Imaging) German researchers have developed a novel diagnostic and therapeutic (theranostic) procedure for patients with ductal pancreatic adenocarcinoma, a deadly cancer with an extremely poor prognosis (five-year survival rate of less than 5 percent) and limited treatment options. The study is featured in the May issue of The Journal of Nuclear Medicine.

Leave A Reply

Your email address will not be published.